Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Clinical trial NCT04858568 · COMPLETED

Trial details

NCT number: NCT04858568
Sponsor: University Hospital Southampton NHS Foundation Trust
Status: COMPLETED
Study type: OBSERVATIONAL

Classical Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Primary Mediastinal B Cell Lymphoma High-grade B-cell Lymphoma Burkitt Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Lymphoplasmacytic Lymphoma Nodular Lymphocyte Predominant Hodgkin Lymphoma

Start date: 2021-03-11
Primary completion: 2022-10-31
Enrollment: 592

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.